Research map: Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · 2026 · Related
  3. The REDCap consortium: Building an international community of software platform partners · Paul A. Harris · 2019 · 25228 citations · Cited by this paper
  4. Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · 2026 · Related
  5. Circulating mutant DNA to assess tumor dynamics · Frank Diehl · 2008 · 2772 citations · Cited by this paper
  6. Exploration of the Challenges in the Management of Prostate Cancer in East Africa · 2025 · Related
  7. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer · Jeanne Tie · 2022 · 1082 citations · Cited by this paper
  8. Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study · 2026 · Related
  9. Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies · Jenny Lee · 2018 · 326 citations · Cited by this paper
  10. Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · 2026 · Related
  11. Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. · Heide S. Puc · 1996 · 202 citations · Cited by this paper
  12. Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) · 2026 · Related
  13. Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers · Aparna R. Parikh · 2020 · 146 citations · Cited by this paper
  14. Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · 2026 · Related
  15. ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer · Thomas B. Powles · 2025 · 143 citations · Cited by this paper
  16. A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer · 2025 · Related
  17. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. · Sidney Schultz · 1989 · 138 citations · Cited by this paper
  18. Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy · Jeffrey C. Thompson · 2021 · 108 citations · Cited by this paper
  19. Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration · Patrizia Giannatempo · 2015 · 95 citations · Cited by this paper
  20. Management of Post-Chemotherapy Residual Masses in Advanced Seminoma · Aude Fléchon · 2002 · 91 citations · Cited by this paper
  21. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer · Marguerite C. Lippert · 1981 · 77 citations · Cited by this paper
  22. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors · Lucia Nappi · 2020 · 67 citations · Cited by this paper
  23. Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review · Emanuele Crupi · 2023 · 65 citations · Cited by this paper
  24. Serum tumour markers in germ cell tumours: From diagnosis to cure · Paolo Pedrazzoli · 2021 · 64 citations · Cited by this paper
  25. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma · Felix Seelemeyer · 2023 · 25 citations · Cited by this paper
  26. The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis · Qiangzhao Liu · 2021 · 17 citations · Cited by this paper
  27. Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas · Kim M. Tsoi · 2021 · 16 citations · Cited by this paper
  28. Methylation profiles of imprinted genes are distinct between mature ovarian teratoma, complete hydatidiform mole, and extragonadal mature teratoma · Noriko Kato · 2020 · 14 citations · Cited by this paper
  29. Clinical utility of tumour‐informed circulating tumour DNA in patients with testicular cancer · Reuben Ben‐David · 2025 · 11 citations · Cited by this paper
  30. Clinical performance of Signatera Genome assay in a cohort of patients (pts) with solid tumors. · Mridula Annette George · 2025 · 10 citations · Cited by this paper
  31. Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors · Rebecca Hassoun · 2025 · 6 citations · Cited by this paper
  32. Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ Tumor · Parth Udayan Thakker · 2026 · 4 citations · Cited by this paper
  33. Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease · Willian Ito · 2026 · 1 citation · Cited by this paper
  34. Circulating Tumor DNA as a Novel Indicator of Teratoma in Nonseminomatous Germ Cell Tumor · Willian Eduardo Ito · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)